News about Global Pharma

Healx Secures Investment Agreement with Children's Tumor Foundation

The agreement entails payments from CTF to support the advancement of Healx's AI-powered neurofibromatosis program, particularly focusing on its lead candidate, HLX-1502, slated to enter a Phase 2 clinical trial in the near future.

Global Pharma | 11/04/2024 | By Abha |  614

Nuevocor Appoints Dr. John Lee as Chief Medical Officer

In response to his appointment, Dr. Lee expressed enthusiasm about joining Nuevocor and leading the clinical development efforts for the LMNA DCM program.

Global Pharma | 11/04/2024 | By Abha |  1189

Dr. Reddys Unveils Drug-Free Migraine Management Device in Europe

Dr. Reddy’s Laboratories Ltd. has introduced the non-invasive migraine management wearable device, Nerivio in Germany through its step-down subsidiary Betapharm.

Global Pharma | 11/04/2024 | By Aishwarya |  1270

Sanofi Receives Nod for IMOVAX-Polio in India

Sanofi has gained approval for IMOVAX-Polio, an alternative injectable vaccine.

Global Pharma | 11/04/2024 | By Aishwarya |  762

Aptar Pharma Gets NMPA Nod for Airless Drug Delivery System

Aptar Pharma has received approval by the National Medical Products Administration (NMPA) in China of Sinomune Pharmaceutical’s Li Fu metronidazole gel.

Global Pharma | 11/04/2024 | By Aishwarya |  937

Strides Pharma Receives FDA Approval for Antidepressant Drug

Strides Pharma Science’s subsidiary has gained approval from the US health regulator to market a generic antidepressant medication.

Global Pharma | 10/04/2024 | By Aishwarya |  1249

MOLLI Surgical Introduces OncoPen: A Revolutionary Tool in Breast Cancer Surgery

This sleek, pen-like wand seamlessly integrates with the acclaimed MOLLI® 2 System, providing sophisticated tools for precisely targeting and removing cancerous lesions.

Global Pharma | 10/04/2024 | By Abha |  698

Texas Cardiac Arrhythmia Institute Makes Medical Breakthrough with Novel Pulsed Field Ablation System

This heart arrhythmia, affecting millions worldwide, has seen a revolutionary approach after receiving approval from the US Food and Drug Administration.

Global Pharma | 10/04/2024 | By Abha |  462

Nvelop Therapeutics to Launch Dual Platforms for In Vivo Delivery of Next-Gen of Genetic Medicines

Nvelop Therapeutics has officially announced to develop the next generation of genetic medicines for a wide range of diseases.

Global Pharma | 10/04/2024 | By Aishwarya |  719

Invenra Signs Research Deal with Astellas Pharma to Boost Bispecific Therapeutic Research

Invenra Inc. has forged a strategic research agreement with Astellas Pharma, a global pharmaceutical company with a vision to turn innovative science into value for patients.

Global Pharma | 10/04/2024 | By Aishwarya |  716